Corporate overview

genOway has established successful partnerships with the following companies and research institutes and is an active member of number of research consortiums and networks.

Strategic Alliances

Charles River Laboratories (Mass. USA) is the world leader in animal breeding and related services. A partnership is in place to co-promote our service offer. This collaboration provides the customers of each company with the services and products of the highest quality.Consult the Press releases for European and North American collaborations

Invitrogen Corporation (Cal, USA) is a provider of products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide. Invitrogen and genOway combine their in vitro & in vivo technological platform to offer a complete range of RNAi services to the Biopharmaceutical industry. This strategic alliance in the RNAi field, the fastest growing market in drug discovery provides reduced development time and more robust technologies for target validation programs.Consult the Press release

TET Systems Holding GmbH & Co. KG (Heidelberg, Germany) founded by Professor Hermann Bujard and the co-inventors of the TET gene control technology serves the needs of licensees to successfully apply the TET Technology. Combining New Tetracycline system with LC1 technologies enables for the first time the creation of reliable disease models based on "on demand" gene induction, mimicking disease onset and development. With the acquisition of the exclusive license for both New Tetracycline and LC1 technologies for research model creation business, genOway is now the only company to offer a reliable in vivo inducible system.

Joint research programs

Rat Consortium: genOway is currently coordinating a Rat Consortium with Pharmaceutical companies, biotechnological companies and leading academic centers.Consult the web page

Pfizer (NY, USA) is the world's largest pharmaceutical company devoted to health care. Pfizer Inc discovers, develops, manufactures and markets leading prescription medicines, for humans and animals. genOway has entered into a research agreement with Pfizer, to provide Pfizer researchers in the U.S. with a genetically modified rat model based on genOway's nuclear transfer technology.
Consult the Press release

Altana Pharma (Konstanz, Germany) is the pharmaceutical division of ALTANA AG with more than 8,200 employees and 30 subsidiaries in Europe, North and South America, Asia, South Africa and Australia. The cooperation establishes that genOway will provide ALTANA Pharma's drug discovery and development programs with a genetically modified rat model generated using genOway's innovative nuclear transfer technology.Consult the Press release

EURATOOLS: genOway is involved in the European Rat Tools for Functional Genomics (EU 6th Framework) project as a SME Partner. EURATOOLS integrates European excellence in research relevant to rat physiology, pharmacology and genetics, to develop innovative high throughput tools and technologies to facilitate the generation of large data sets for deciphering gene function in the rat.